In an exploratory analysis of a subset of more difficult‐to‐treat asthma (n = 27 IFN‐β; n = 31 placebo), worsening of symptoms increased significantly in the placebo group, but was prevented by IFN‐β (P = 0·004).80 Here, IFNB1 is linked to asthma.